Upcoming Event: The Cell Therapy Insights Series

The Cell Therapy Insights Series, “Cell Therapy Insights,” is a series of events and presentations focusing on the influence of the cell therapy community in shaping the future of cell therapy development. These sessions aim to bridge the gap from early research to real-world, clinical applications.

The Cell Therapy Insights Series April 8, 2025

Presented by Cellerator and Thermo Fisher Scientific, the “Cell Therapy Insights Series” features innovators and pioneers who share their experiences and knowledge about progressing from pre-clinical stages to clinical proof of concept. Attendees will have the opportunity to learn from leading experts and exchange their own insights and experiences with peers in this rapidly evolving field.

The talks are held at the Novo Nordisk Foundation headquarters in Hellerup, Copenhagen. Join fellow developers and other professionals for an informative session centered on the translation of cell therapy drug products from pre-clinical proof of concept to first human dose.

Dr. Anthony Ting will provide valuable insights based on multiple rounds of cell therapy development.

The event will also include an interactive session designed to investigate the impact of key decisions in product development. Updates from Cellerator and Thermo Fisher Scientific will be provided, followed by a networking opportunity. The event will be accessible online, featuring interactive components and Q&A sessions.

About the April Event

Presented by Dr. Anthony Ting. Dr. Ting is the Chief Scientific Officer (CSO) for Kiji Therapeutics, which is developing off-the-shelf engineered cell therapies. He has over 30 years of academic and industry experience in translational science. He also leads BRL C&GT Consulting and was recently the Chief Commercialization Officer for the International Society for Cell and Gene Therapy (ISCT). Prior to joining Kiji Therapeutics, he served as Program Leader in Oncology Cell Therapy Innovation at Takeda. Dr. Ting was also the CSO for Bone Therapeutics and the Vice President of Regenerative Medicine at Athersys. He received his PhD from Johns Hopkins, followed by a post-doctoral fellowship at Stanford.

AGENDA

11:00 - Light lunch, Atrium of the Novo Nordisk Foundation

12:00 - Welcome by Thomas Carlsen, Cellerator

12:05 - From Bench to Bedside: Lessons Learned in Cell Therapy, by Anthony Ting

13:00 - Interactive product developer journey

14:15 - Break

14:30 - Presentation of the Cellerator Translational Framework

15:00 - Panel Discussion, Moderated by Jakob Gudbrand, Thermo Fisher Scientific

Anthony Ting, Kiji Therapeutics
Mark Denham, Aarhus University
Agnete Kirkeby, Copenhagen University
Mauro Sbroggiò, Cellerator
Timothy Miller, Thermo Fisher Scientific

15:45 - Networking, Atrium of the Novo Nordisk Foundation

16:30 - That’s a wrap! Thanks for a great day, and see you next time!

Reach out to hear more